The expression of PTGIS was absolutely lower in bladder cancer, cervical cancer, colorectal cancer, head and neck cancer, leukemia, lung cancer, ovarian cancer, and prostate cancer than in normal samples. This evidence concerns the gene PTGIS and ovarian carcinoma.